Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1991
11/28/1991WO1991017770A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy
11/28/1991WO1991017768A1 Epitopes of the pre-s region of hepatitis b virus surface antigen
11/28/1991CA2083391A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy
11/28/1991CA2083150A1 Synthetic senescent cell antigen
11/27/1991EP0458668A1 Papilloma virus probe (HPV66), particularly for the diagnosis of papillomaviral infections in vitro which accompany genital neoplasia, as well as products genetically and immunologically related to this papilloma virus
11/27/1991EP0458072A1 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody
11/27/1991EP0457875A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
11/27/1991CN1056428A Actinobacillus pleuropneumoniae subunit vaccine
11/26/1991WO1991018618A2 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection
11/26/1991US5068192 Attenuated pseudorabies virus which includes foreign DNA encoding an amino acid sequence
11/26/1991US5068177 Anti-idiotype antibodies induced by synthetic polypeptides
11/26/1991US5068104 Live vaccine for coccidiosis utilizing coccidial sporozoites
11/26/1991CA2062758A1 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection
11/24/1991WO1991018107A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy
11/24/1991CA2083598A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy
11/23/1991WO1991017769A1 Novel methods for producing antigen-specific, high-affinity human monoclonal antibodies
11/23/1991CA2082041A1 Methods for producing antigen-specific, high-affinity human monoclonal antibodies
11/21/1991EP0457532A1 Monoclonal antibody which inhibits the biological action of platelet factor 4
11/21/1991EP0457438A2 Conjugate compounds containing aza-macrocycles, and processes for their preparation
11/21/1991EP0457250A2 Novel bifunctional linking compounds, conjugates and methods for their production
11/21/1991EP0457213A2 Barbiturate assay, tracers, immunogens, antibodies and kit
11/21/1991EP0456727A1 Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof
11/21/1991EP0456719A1 Anti-idiotype antibodies reactive with shared idiotopes expressed by human lymphomas and autoantibodies
11/21/1991EP0456662A1 Vaccine for the preventative treatment of infection of liver fluke in ruminants
11/20/1991CN1056314A Bacterial strain and its utilization
11/20/1991CN1056245A Bcrf1 antagonists for treating epstein-barr virus infections
11/20/1991CN1056240A Inhibition nf allograft and concordant xenograft rejection
11/19/1991US5066782 Retrovirus capable of causing AIDS, means and method for detecting it in vitro
11/19/1991US5066593 Synthetic peptide-based anti-rabies compositions and methods
11/19/1991US5066579 HTLV-I peptide antigen and assay
11/19/1991US5066492 Method of treating herpes simplex virus
11/19/1991US5066490 Protein crosslinking reagents cleavable within acidified intracellular vesicles
11/17/1991WO1991017764A1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding
11/16/1991CA2042437A1 Immunologic enhancement of the somatogenic effect of somatotrophin with an antibody
11/14/1991WO1991017249A1 Interleukin-1 antagonist and uses thereof
11/14/1991WO1991017248A1 Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
11/14/1991WO1991017174A1 Dna encoding human 5-ht1d receptors and uses thereof
11/14/1991WO1991016925A1 Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines
11/14/1991WO1991016924A1 Enhancing the association of exogenous peptides with class i mhc molecules on immune system cells
11/14/1991WO1991016922A1 Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity
11/14/1991WO1991016921A1 Method and composition for the treatment of cancer
11/14/1991DE4014510A1 Variante cd44-oberflaechenproteine, diese kodierende c-dna-sequenzen, antikoerper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie Variant CD44-oberflaechenproteine, this encoding c-dna sequences, antibodies against these proteins and their use in the diagnosis and therapy
11/14/1991CA2374571A1 Dna encoding human 5-ht1d receptors and uses thereof
11/14/1991CA2081774A1 Interleukin-1 antagonist and uses thereof
11/13/1991EP0456215A1 Monoclonal antibodies to pres2 and pres1 polypeptides of the hepatitis B viral envelope
11/13/1991EP0456197A1 Seroreactive epitopes from proteins of human papilloma virus (HPV) 18
11/13/1991EP0455682A1 Polypeptides having a human beta-adrenergic receptor activity, and playing a role in lipolytic response, nucleic acids coding for these polypeptides and use of said polypeptides for screening substances which act on these polypeptides.
11/13/1991EP0152468B1 Production of streptococal m protein immunogens and molecular probes
11/12/1991WO1991018118A1 Papillomavirus probe (hpv66), particularly for the diagnosis in vitro of papillomavirus infections which may be accompanied by genital neoplasia, and products genetically and immunologically related to said papillomavirus
11/12/1991WO1991018100A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity
11/12/1991US5064942 New protein tetranectin isolated from human blood
11/12/1991US5064647 Culture, poultry
11/12/1991US5064646 In poultry, which will not bind to monoclonal antibodies that bind to current vaccines; live or killed vaccines
11/12/1991CA2064060A1 Papillomavirus (hpv66) probe, particularly for the in vitro diagnosis of papillomavirus infections possibly accompanied with genital neoplasia, and products genetically and immunologically related to this papillomavirus
11/12/1991CA2041772A1 Monoclonal antibodies to pres2 and pres1 polypeptide of the hepatitis b viral envelope
11/10/1991CA2042085A1 Process for the preparation of retrovirus immunogens and vaccines against retroviral, notably hiv, infections and obtained immunogens and vaccines
11/09/1991WO1991016912A1 Metal binding proteins
11/09/1991CA2081213A1 Metal binding proteins
11/08/1991WO1991016926A1 Vaccine compositions
11/08/1991CA2082425A1 Vaccine compositions
11/07/1991DE4005874A1 Traegergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine Traegergebundene recombinant proteins, methods for production and use as immunogens and vaccines
11/06/1991EP0454767A1 Compositions and methods for treating or preventing aids, arc and hiv infection
11/06/1991EP0454766A1 Polyvalent metal ion-containing antibody combining site catalysts
11/06/1991EP0454765A1 Pregnancy specific proteins applications
11/06/1991EP0454733A1 Osmotically dependent vesicles
11/06/1991EP0454726A1 Hindered linking agents and methods
11/06/1991EP0203107B1 Specific carbohydrate-binding proteins (lectins) of mammalian tumor cells
11/06/1991CN1055879A Antibody conjugates for treatment of neoplastic disease
11/06/1991CN1055876A Inhibitors of advanced glycosylation of proteins and method of use therefor
11/05/1991WO1991017186A1 Beta cell antigen
11/05/1991US5063210 Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
11/05/1991US5063150 Immunology
11/05/1991CA2082162A1 Beta cell antigen
11/04/1991WO1991016910A1 Human lymphoid tissue in an immunocompromised host
11/04/1991CA2063408A1 Human lymphoid tissue in an immunocompromised host
11/04/1991CA2041814A1 Prohylaxis of pasteurellosis in animals
10/1991
10/31/1991WO1991016629A1 Ctaa 28a32, the antigen recognized by mca 28a32
10/31/1991WO1991016437A1 Soluble peptide analogues containing binding sites
10/31/1991WO1991016430A1 NOVEL T-CELL LYMPHOMA cDNA CLONES
10/31/1991WO1991016354A1 Processes and intermediates for synthetic antibody derivatives
10/31/1991WO1991016347A1 Composition for macrophage activation
10/31/1991WO1991016073A1 Oral vaccine comprising antigen surface-associated with red blood cells
10/31/1991WO1991016072A1 Hydroxyapatite-antigen conjugates and methods for generating a poly-ig immune response
10/31/1991WO1991016071A1 Antibody conjugates for treatment of neoplastic disease
10/31/1991WO1991016068A1 Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
10/31/1991WO1991016061A1 SYNTHETIC POLY-Ig RECEPTOR, RECEPTOR-ANTIBODY COMPLEXES, PRODUCTION AND USE THEREOF
10/31/1991DE4037604A1 Use of anti-TNF antibodies to treat ischaemia and its sequelae - esp. to increase survival rate after myocardial infarct and transplants
10/31/1991CA2081207A1 Soluble peptide analogues containing binding sites
10/31/1991CA2080477A1 Oral vaccine comprising antigen surface-associated with red blood cells
10/31/1991CA2079601A1 Ctaa 28a32, the antigen recognized by mca 28a32
10/31/1991CA2059289A1 Synthetic poly-ig receptor, receptor-antibody complexes, production and use thereof
10/30/1991EP0454044A2 Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance
10/30/1991EP0453898A2 Use of TNF-specific antibodies as a drug for treatment of ischemias and of their consequences
10/30/1991EP0453561A1 Chimeric mouse human antibodies with specificity to hiv antigens
10/30/1991EP0453560A1 Localization and characterization of the wilms's tumor gene
10/30/1991EP0453556A1 Pneumocystis carinii dihydrofolate reductase gene and methods for its use
10/30/1991EP0453497A1 Treatment methods and vaccines
10/30/1991EP0453452A1 Vaccine
10/30/1991CN1055819A Pharmaceutical containing episialo complex carbohydrate
10/29/1991US5061790 Cleavage of sulfur-sulfur bonds
1 ... 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 ... 1823